Biostax Corp.
OTC: BTAX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Noreen Griffin
- Employees
- 4
- Headquarters
- Winter Park, United States
- IPO year
- 2010
- Market cap
- $7.9K
- Website
- https://www.biostaxcorp.com
Loading BTAX…
Loading profile data…Frequently asked questions about BTAX
What does Biostax Corp. (BTAX) do?
Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition, advancement, and commercialization of various pharmaceutical and biotechnology solutions. A pivotal focus lies on Lodonal, their lead investigational drug candidate, designed as a once-daily immune system modulator aimed at managing both human immunodeficiency virus an...
Where does BTAX trade?
Biostax Corp. (BTAX) trades on the Other OTC.
What sector is BTAX in?
Biostax Corp. (BTAX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Biostax Corp.?
Noreen Griffin is the chief executive officer of Biostax Corp. (BTAX).
Where is Biostax Corp. headquartered?
Biostax Corp. is headquartered in United States.
Does BTAX pay a dividend?
Biostax Corp. (BTAX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BTAX go public?
Biostax Corp. (BTAX) completed its initial public offering in 2010.